跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
TRURAPI
Authorized
STANDARD
TRURAPI
sanofi-aventis canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
423b68f0c605b87c
Company
sanofi-aventis canada inc
Type
Standard
Approval Details
Approval Id
423b68f0c605b87c
Drug Approval Canada Name
TRURAPI
Product Name
TRURAPI
Status
Marketed
Status Date
2022-11-03
Original Market Date
2022-11-03
Din
02529254
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous , Intravenous
Schedule
Schedule D
Ahfs
68:20.08
Atc Original
A10AB05 INSULIN ASPART
Atc Name
a 10 ab 05
Aig Number
0144802001
Company Name
sanofi-aventis canada inc
Company Address
1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4
Active Ingredients
INSULIN ASPART
100 UNIT / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
423b68f0c605b87c
Type
Standard
Back to Health Canada Approvals
TRURAPI - Health Canada Drug Approval Details